Preparative and Process Chromatography Market - Global Forecast to 2031
Preparative and Process Chromatography Market by Product [Preparative (Columns, System), Process (Resins, Services)], Application (Vaccines, Peptides & Oligonucleotides), End User (Food & Nutraceutical Companies, Others), Region - Global Forecast to 2031
分取クロマトグラフィーとプロセスクロマトグラフィー市場 - 製品[分取(カラム、システム)、プロセス(樹脂、サービス)]、用途(ワクチン、ペプチド、オリゴヌクレオチド)、エンドユーザー(食品・機能性食品企業、その他)、地域別 - 2031年までの世界予測
| 出版 | MarketsandMarkets |
| 出版年月 | 2026年02月 |
| ページ数 | 256 |
| 図表数 | 257 |
| 価格 | 記載以外のライセンスについてはお問合せください |
| シングルユーザ | USD 4,950 |
| 種別 | 英文調査報告書 |
| 商品番号 | SMR-14144 |
世界の分取クロマトグラフィーとプロセスクロマトグラフィー市場は、予測期間中に年平均成長率8.2%で成長し、2026年の143.2億米ドルから2031年には215億米ドルに達すると予測されています。
一部の先進国では、より個別化された治療への需要が高まる中、CGT、オリゴ、mRNAといった新たなモダリティを用いたワクチンや組換えタンパク質の生産量が増加すると予想されています。生産量の増加に伴い、多様な生物製剤の精製が必要となります。こうした変化により、クロマトグラフィーは特に捕捉と精製において重要な単位操作となり、市場の成長余地を生み出しています。モノクローナル抗体(mAb)の世界的なパイプラインは拡大しており、FDA承認件数の増加や、二重特異性抗体や抗体薬物複合体(ADCP)の新規上市が目立っています。これにより、エンドユーザーの精製ニーズが高まり、分取およびプロセスクロマトグラフィー製品の市場拡大が期待されます。
調査範囲
本調査レポートでは、分取クロマトグラフィーとプロセスクロマトグラフィー市場を製品、用途、エンドユーザー、地域別に分析しています。市場成長を促進する要因、業界をまたぐ課題と機会、そして市場リーダーや中小企業を含む競争環境を検証しています。また、5つの地域における様々な市場セグメントの収益予測と、マイクロマーケット分析も含まれています。
レポートを購入する理由
本レポートは、分取クロマトグラフィーとプロセスクロマトグラフィー市場全体とそのサブセグメントの正確な収益予測を提供することで、市場リーダー企業と新規参入企業を支援します。また、ステークホルダーが競争環境を理解し、より効果的な事業展開と適切な市場開拓戦略の策定を支援します。さらに、主要な推進要因、制約要因、課題、機会など、市場動向に関する洞察も提供します。
本レポートでは、以下の点に関する有益なデータを提供しています。
- 市場浸透:分取クロマトグラフィーとプロセスクロマトグラフィー市場における主要企業が提供する製品ポートフォリオの詳細な分析
- 製品開発/イノベーション:分取クロマトグラフィーとプロセスクロマトグラフィー市場における主要企業が提供する製品ポートフォリオの詳細な分析
- 市場発展:収益性の高い開発分野に関する有益なデータ
- 市場多様化:分取クロマトグラフィーとプロセスクロマトグラフィー市場における最近の開発状況と進歩に関する詳細な情報
- 競合評価:主要競合他社の製品、成長戦略、収益予測、市場カテゴリーに関する詳細な評価
Report Description
The global preparative and process chromatography market is projected to reach USD 21.50 billion by 2031 from USD 14.32 billion in 2026, growing at a CAGR of 8.2% during the forecast period.

Preparative and Process Chromatography Market – Global Forecast to 2031
Vaccines and recombinant proteins using new modalities such as CGT, oligos, and mRNA are expected to grow in volume as demand for more personalized treatments rises in some developed economies. With increased volume, this diversity of biologics needs to be purified. These shifts make chromatography a critical unit operation, especially for capture and purification, creating space for market growth. The global monoclonal antibody (mAb) pipeline is expanding, marked by high FDA approvals and new bispecific and antibody-drug conjugate launches. This has helped boost purification requirements among end users, which is expected to increase the market for preparative and process chromatography products.
“Based on product type, process chromatography products held the largest share of the market in 2025.”
Based on product, the preparative and process chromatography market is segmented into preparative chromatography and process chromatography. Process chromatography accounted for the largest share of the market. Global pharmaceutical and biopharmaceutical end users—which include major pharma facilities and CDMOs—are focused on commercial downstream workflows designed for process chromatography rather than preparative stages. New plants or large-scale manufacturing facilities drive recurring, multi-year demand for process resins, columns, and services. These factors helped process-scale chromatography products capture the largest share of the global market.
“Based on applications, the monoclonal antibodies and recombinant proteins segment held the largest share in 2025.”
By application, the market for preparative and process chromatography is categorized into monoclonal antibodies & recombinant proteins, vaccines, peptides and oligonucleotides, cell and gene therapies, and other applications. The monoclonal antibodies & recombinant proteins production application acquired the largest market share in 2025. Monoclonal antibodies (mAbs) have become a widely adopted biotherapeutic modality across oncology, immunology, infectious disease, and rare disease indications. Regulatory pathways are well established, manufacturing processes are standardized, and biosimilar competition has driven market growth. Standardized, multi-step purification workflows drive consistent resin and consumables demand. The industry has converged on proven three-step chromatography trains for mAb purification: Protein A affinity capture (to isolate the target antibody from cell culture fluid), intermediate polishing (typically ion-exchange to remove aggregates and remaining impurities), and final polishing (to achieve specification-grade purity and remove residual ligands). These factors have helped the monoclonal antibodies & recombinant proteins production application segment acquire the largest share.
“Based on end user, the pharma and biopharma companies segment accounted for the largest share in 2025.”
By end user, the preparative and process chromatography market is categorized into pharma & biopharma companies, food & nutraceutical companies, research & academia, and other end users. Pharma & biopharma companies held the largest share in 2024. Integrated pharmaceutical and biopharmaceutical manufacturers represent the anchor customer base for preparative and process chromatography, driven by their need to produce large-scale commercial biologics with consistent quality, high yield, and regulatory compliance. These organizations operate dedicated downstream facilities optimized for mAb, recombinant protein, and vaccine purification, requiring a continuous supply of resins, columns, systems, and technical support. Large pharma companies maintain in-house process development and manufacturing expertise and invest heavily in advanced chromatography platforms. The stability and scale of these operations, combined with their strict quality and regulatory requirements, make them a key end user segment with significant demand. These factors have helped them acquire the largest share.
“North America is expected to hold a significant share in the preparative and process chromatography market throughout the forecast period.”
The preparative and process chromatography market comprises five main regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2025, North America held a significant share of the market for preparative and process chromatography products. Its dominant position stems from increased manufacturing capacity focused on both commercial-scale and clinical-trial supply production. Investment trends indicate that US federal and state support promotes domestic biomanufacturing for pandemic preparedness and to reduce reliance on international supply chains. Small- to mid-sized biotech firms are increasingly partnering with CDMOs. These factors helped North America secure the largest market share in 2025.
A breakdown of the primary participants referred to for this report is provided below:
- By Company Type: Tier 1 (35%), Tier 2 (45%), and Tier 3 (20%)
- By Designation: C-level Executives (35%), Directors (25%), and Others (40%)
- By Region: North America (40%), Europe (30%), Asia Pacific (20%), Latin America (5%), and the Middle East & Africa (5%)
The key players profiled in the preparative and process chromatography market are Danaher Corporation (US), Repligen Corporation (US), Merck KGaA (Germany), Thermo Fisher Scientific (US), Agilent Technologies, Inc. (US), Bio-Rad Laboratories, Inc. (US), Avantor, Inc. (US), Sartorius AG (Germany), Shimadzu Corporation (Japan), Ecolab Inc. (US), Tosoh Bioscience (Japan), Mitsubishi Chemical Group Corporation (Japan), Revvity (US), PerkinElmer (US), Cecil Instruments Limited (UK), W.R. Grace & Co. (US), Ecom SPO (Czech Republic), BUCHI Labortechnik AG (Switzerland), Good Science (Tianjin) Instrument Technologies Co., Ltd. (China), Bio Works Technologies (Sweden), Sykam GmbH (Germany), Sunresin New Materials Co., Ltd. (China), YMC Co., Ltd. (Japan), and Geno Technology Inc. (US)

Preparative and Process Chromatography Market – Global Forecast to 2031 – ecosystem
Research Coverage
The research report analyzes the preparative and process chromatography market by product, application, end user, and region. It examines the factors driving market growth, the challenges and opportunities across industries, and the competitive landscape, including market leaders and small- to medium-sized enterprises. It also estimates revenue for different market segments across five regions and includes a micromarket analysis.
Reasons to Buy the Report
The report will help market leaders and new entrants by providing accurate revenue estimates for the entire preparative and process chromatography market and its subsegments. It will help stakeholders understand the competitive landscape, enabling them to position their businesses more effectively and develop suitable go-to-market strategies. Additionally, the report offers insights into market dynamics, including key drivers, restraints, challenges, and opportunities.
This report provides insightful data on the following.
- Market Penetration: In-depth coverage of product portfolios offered by the top players in the preparative and process chromatography market
- Product Development/Innovation: In-depth coverage of product portfolios offered by the top players in the preparative and process chromatography market
- Market Development: Insightful data on profitable developing areas
- Market Diversification: Details about recent developments and advancements in the preparative and process chromatography market
- Competitive Assessment: Extensive assessment of the products, growth tactics, revenue projections, and market categories of the top competitors
Table of Contents
1 INTRODUCTION 25
1.1 STUDY OBJECTIVES 25
1.2 MARKET DEFINITION 25
1.3 STUDY SCOPE 26
1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE 26
1.3.2 INCLUSIONS & EXCLUSIONS 27
1.3.3 YEARS CONSIDERED 28
1.4 CURRENCY CONSIDERED 28
1.5 STAKEHOLDERS 28
1.6 SUMMARY OF CHANGES 29
2 EXECUTIVE SUMMARY 30
2.1 MARKET HIGHLIGHTS & KEY INSIGHTS 30
2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS 31
2.3 DISRUPTIVE TRENDS IN PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET 32
2.4 HIGH-GROWTH SEGMENTS 33
2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST 34
3 PREMIUM INSIGHTS 35
3.1 PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET OVERVIEW 35
3.2 ASIA PACIFIC PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET,
BY END USER AND COUNTRY 36
3.3 PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET:
GEOGRAPHIC GROWTH OPPORTUNITIES 37
4 MARKET OVERVIEW 38
4.1 INTRODUCTION 38
4.2 MARKET DYNAMICS 38
4.2.1 DRIVERS 39
4.2.1.1 Increased demand for complex biologics and advanced
therapeutic modalities 39
4.2.1.2 Increased outsourcing to CDMOs 39
4.2.1.3 Technological advancements in chromatography media and systems 40
4.2.1.4 Need for cost optimization in downstream processing 40
4.2.2 RESTRAINTS 41
4.2.2.1 Lowered replacement rate due to incomplete single-use adoption 41
4.2.2.2 Limited resin lifetime and performance degradation 41
4.2.3 OPPORTUNITIES 42
4.2.3.1 Ongoing investments in bioprocessing capacity and
analytical capabilities 42
4.2.3.2 Expansion of integrated, intensified, and
continuous chromatography columns 42
4.2.4 CHALLENGES 43
4.2.4.1 Shortage of skilled chromatography professionals 43
4.2.4.2 High capital and operating costs 43
4.3 UNMET NEEDS 44
4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES 44
4.5 STRATEGIC MOVES BY TIER1/2/3 PLAYERS 45
4.5.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET 45
5 INDUSTRY TRENDS 48
5.1 PORTER’S FIVE FORCES ANALYSIS 48
5.1.1 BARGAINING POWER OF BUYERS 49
5.1.2 BARGAINING POWER OF SUPPLIERS 49
5.1.3 THREAT OF NEW ENTRANTS 49
5.1.4 THREAT OF SUBSTITUTES 49
5.1.5 INTENSITY OF COMPETITIVE RIVALRY 49
5.2 MACROECONOMIC INDICATORS 49
5.2.1 INTRODUCTION 49
5.2.2 GDP TRENDS & FORECAST 50
5.2.3 TRENDS IN GLOBAL BIOPROCESS INDUSTRY 50
5.3 SUPPLY CHAIN ANALYSIS 50
5.3.1 PROMINENT COMPANIES 50
5.3.2 SMALL & MEDIUM-SIZED ENTERPRISES 51
5.3.3 END USERS 51
5.4 VALUE CHAIN ANALYSIS 52
5.4.1 RESEARCH & PRODUCT DEVELOPMENT 52
5.4.2 RAW MATERIAL PROCUREMENT 52
5.4.3 MANUFACTURING 52
5.4.4 DISTRIBUTION, MARKETING & SALES, AND POST-SALES SERVICES 52
5.5 ECOSYSTEM ANALYSIS 54
5.6 PRICING ANALYSIS 55
5.6.1 AVERAGE SELLING PRICE OF PREPARATIVE AND PROCESS CHROMATOGRAPHY PRODUCTS, BY KEY PLAYER, 2025 55
5.6.2 AVERAGE SELLING PRICE OF PREPARATIVE AND PROCESS CHROMATOGRAPHY PRODUCTS, BY REGION, 2025 56
5.7 TRADE ANALYSIS 58
5.7.1 IMPORT DATA (HS CODE 902720) 58
5.7.2 EXPORT DATA (HS CODE 902720) 59
5.8 KEY CONFERENCES & EVENTS, 2026–2027 60
5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 61
5.10 INVESTMENT & FUNDING SCENARIO 62
5.11 CASE STUDY ANALYSIS 64
5.12 IMPACT OF 2025 US TARIFFS ON PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET 66
5.12.1 INTRODUCTION 66
5.12.2 KEY TARIFF RATES 66
5.12.3 PRICE IMPACT ANALYSIS 67
5.12.4 IMPACT ON COUNTRY/REGION 67
5.12.4.1 US 67
5.12.4.2 Europe 68
5.12.4.3 Asia Pacific 68
5.12.5 IMPACT ON END-USE INDUSTRIES 68
6 STRATEGIC DISRUPTIONS THROUGH TECHNOLOGY, PATENTS,
AND DIGITAL & AI ADOPTION 69
6.1 KEY EMERGING TECHNOLOGIES 69
6.1.1 RECOMBINANT PROTEIN A LIGAND ENGINEERING 69
6.1.2 ALKALINE-STABLE LIGAND DEVELOPMENT 69
6.2 COMPLEMENTARY TECHNOLOGIES 69
6.2.1 AUTOMATED COLUMN PACKING SYSTEMS 69
6.2.2 IN-LINE MONITORING AND PAT (PROCESS ANALYTICAL TECHNOLOGY) 69
6.3 ADJACENT TECHNOLOGIES 70
6.3.1 CONTINUOUS CHROMATOGRAPHY SYSTEMS 70
6.3.2 AFFINITY MEMBRANE TECHNOLOGY 70
6.4 PATENT ANALYSIS 71
6.5 IMPACT OF AI ON PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET 72
6.5.1 TOP USE CASES & MARKET POTENTIAL 72
6.5.2 BEST PRACTICES IN PREPARATIVE AND PROCESS
CHROMATOGRAPHY MARKET 72
6.5.3 CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN
PREPARATIVE AND PROCESS CHROMATOGRAPHY 74
6.6 SUCCESS STORIES & REAL-WORLD APPLICATIONS 74
7 SUSTAINABILITY & REGULATORY LANDSCAPE 75
7.1 REGULATORY LANDSCAPE & SUSTAINABILITY INITIATIVES 75
7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 75
7.1.2 REGULATORY TRENDS 77
7.1.2.1 North America 77
7.1.2.1.1 US 77
7.1.2.2 Europe 77
7.1.2.3 Asia Pacific 78
7.1.2.4 Rest of the World 78
7.2 INDUSTRY STANDARDS 78
7.2.1 SUSTAINABILITY INITIATIVES 79
7.2.2 IMPACT OF REGULATORY POLICIES ON SUSTAINABILITY INITIATIVES 79
8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 80
8.1 DECISION-MAKING PROCESS 80
8.2 BUYER STAKEHOLDERS & BUYING EVALUATION CRITERIA 80
8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 80
8.2.2 BUYING EVALUATION CRITERIA 81
8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES 82
8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES 83
8.5 MARKET PROFITABILITY 83
9 PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET,
BY PRODUCT TYPE 84
9.1 INTRODUCTION 85
9.2 PROCESS CHROMATOGRAPHY PRODUCTS 85
9.2.1 CHEMICALS & REAGENTS 86
9.2.1.1 Recurring consumption to drive demand for chemicals & reagents 86
9.2.2 RESINS 87
9.2.2.1 Increased purification volume to drive demand for resins 87
9.2.3 COLUMNS 88
9.2.3.1 Reproducible results and low cross-contamination risk to drive demand for columns in process chromatography operations 88
9.2.4 SYSTEMS 89
9.2.4.1 Less changeover time and maintenance needs to boost demand for single-use chromatography systems 89
9.2.5 AFTER-MARKET SERVICES 90
9.2.5.1 Capacity expansions and routine calibration needs to drive market growth 90
9.3 PREPARATIVE CHROMATOGRAPHY PRODUCTS 91
9.3.1 CHEMICALS & REAGENTS 92
9.3.1.1 Method development focus and high-purity results to drive market for reagents in preparative operations 92
9.3.2 RESINS 93
9.3.2.1 Cost-effective supply chain metrics to drive demand for bulk resins 93
9.3.3 COLUMNS 94
9.3.3.1 Flexibility, low sample consumption, and high throughput to drive adoption 94
9.3.4 SYSTEMS 95
9.3.4.1 Biologics innovation and strong mAb pipeline to support demand for systems 95
9.3.5 AFTER-MARKET SERVICES 96
9.3.5.1 Consultative and technical services to drive demand for after-market services 96
10 PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET, BY APPLICATION 98
10.1 INTRODUCTION 99
10.2 MONOCLONAL ANTIBODIES & RECOMBINANT PROTEINS 99
10.2.1 SHIFT TOWARDS MORE COST-EFFECTIVE OPTIONS TO OPEN NEW REVENUE CHANNELS 99
10.3 VACCINES 100
10.3.1 WIDE APPLICATION BASE OF STANDARDIZED CHROMATOGRAPHY TECHNIQUES IN VACCINE MANUFACTURING TO DRIVE MARKET GROWTH 100
10.4 PEPTIDES & OLIGONUCLEOTIDES 101
10.4.1 SHIFT TOWARDS HYBRID SYNTHESIS TO DRIVE MARKET GROWTH 101
10.5 CELL & GENE THERAPIES 102
10.5.1 LOWER TARGET PRODUCT YIELD TO HAMPER GROWTH OF CHROMATOGRAPHY AS PRIMARY TECHNIQUE 102
10.6 OTHER APPLICATIONS 103
11 PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET, BY END USER 104
11.1 INTRODUCTION 105
11.2 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES 105
11.2.1 EXTENSIVE USE IN BIOLOGICAL DRUG PRODUCTION
TO ENSURE STRONG DEMAND 105
11.3 FOOD & NUTRACEUTICAL COMPANIES 106
11.3.1 EXPANDING USE CASES IN NUTRACEUTICAL INDUSTRY
TO BOOST MARKET GROWTH 106
11.4 RESEARCH & ACADEMIC INSTITUTES 107
11.4.1 INCREASING R&D IN DRUG DISCOVERY TO DRIVE
USE OF CHROMATOGRAPHY 107
11.5 OTHER END USERS 108
12 PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET, BY REGION 110
12.1 INTRODUCTION 111
12.2 NORTH AMERICA 111
12.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 112
12.2.2 US 115
12.2.2.1 Expansion in biomanufacturing and domestic capacity to drive market 115
12.2.3 CANADA 117
12.2.3.1 Policy-led capacity build and CDMO growth to drive market 117
12.3 EUROPE 118
12.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 118
12.3.2 GERMANY 122
12.3.2.1 Capacity expansion in end-use facilities to generate new demand channels for target products 122
12.3.3 UK 123
12.3.3.1 Government policies and public-private partnerships to drive market 123
12.3.4 FRANCE 124
12.3.4.1 Demand-side developments to add new revenue channels for chromatography OEMs and suppliers 124
12.3.5 ITALY 126
12.3.5.1 Increased CAPEX from major end-user categories to fuel demand for target products 126
12.3.6 SPAIN 127
12.3.6.1 Increased number of CDMOs and CROs to propel demand for chromatography and related products 127
12.3.7 REST OF EUROPE 128
12.4 ASIA PACIFIC 130
12.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 131
12.4.2 JAPAN 133
12.4.2.1 CDMO capacity expansions, policy backing, and CDMO investments to propel market 133
12.4.3 CHINA 135
12.4.3.1 Robust biopharmaceutical expansion to support demand 135
12.4.4 INDIA 136
12.4.4.1 Growth of pharma and biotech industries to drive demand for preparative and process chromatography 136
12.4.5 AUSTRALIA 137
12.4.5.1 Increasing demand for protein-based therapeutics to drive growth 137
12.4.6 SOUTH KOREA 139
12.4.6.1 Developments in biopharmaceutical sector to drive market growth 139
12.4.7 REST OF ASIA PACIFIC 140
12.5 LATIN AMERICA 141
12.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 142
12.5.2 BRAZIL 145
12.5.2.1 Biomanufacturing emphasis and public–private partnerships to catalyze demand 145
12.5.3 MEXICO 146
12.5.3.1 Supportive government initiatives to boost demand for preparative and process chromatography products 146
12.5.4 REST OF LATIN AMERICA 147
12.6 MIDDLE EAST & AFRICA 148
12.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 149
12.6.2 GCC COUNTRIES 152
12.6.2.1 Favorable government policies to propel market growth 152
12.6.3 REST OF MIDDLE EAST & AFRICA 153
13 COMPETITIVE LANDSCAPE 155
13.1 INTRODUCTION 155
13.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 155
13.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET 156
13.3 REVENUE ANALYSIS, 2020–2024 158
13.4 MARKET SHARE ANALYSIS, 2025 159
13.4.1 MARKET RANKING OF KEY PLAYERS, 2025 161
13.5 COMPANY VALUATION & FINANCIAL METRICS 161
13.5.1 FINANCIAL METRICS 161
13.5.2 COMPANY VALUATION 162
13.6 BRAND/PRODUCT COMPARISON 163
13.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 164
13.7.1 STARS 164
13.7.2 EMERGING LEADERS 164
13.7.3 PERVASIVE PLAYERS 164
13.7.4 PARTICIPANTS 164
13.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 166
13.7.5.1 Company footprint 166
13.7.5.2 Region footprint 167
13.7.5.3 Product type footprint 168
13.7.5.4 Application footprint 169
13.7.5.5 End-user footprint 170
13.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025 171
13.8.1 PROGRESSIVE COMPANIES 171
13.8.2 RESPONSIVE COMPANIES 171
13.8.3 DYNAMIC COMPANIES 171
13.8.4 STARTING BLOCKS 171
13.8.5 COMPETITIVE BENCHMARKING OF STARTUPS/SMES, 2025 173
13.8.5.1 Detailed list of key startups/SMEs 173
13.8.5.2 Competitive benchmarking of key startups/SMEs 174
13.9 COMPETITIVE SCENARIO 176
13.9.1 PRODUCT LAUNCHES 176
13.9.2 DEALS 176
13.9.3 EXPANSIONS 177
14 COMPANY PROFILES 179
14.1 KEY PLAYERS 179
14.1.1 DANAHER 179
14.1.1.1 Business overview 179
14.1.1.2 Products offered 181
14.1.1.3 Recent developments 181
14.1.1.3.1 Product launches 181
14.1.1.3.2 Deals 182
14.1.1.3.3 Expansions 182
14.1.1.4 MnM view 183
14.1.1.4.1 Right to win 183
14.1.1.4.2 Strategic choices 183
14.1.1.4.3 Weaknesses & competitive threats 183
14.1.2 THERMO FISHER SCIENTIFIC INC. 184
14.1.2.1 Business overview 184
14.1.2.2 Products offered 186
14.1.2.3 Recent developments 186
14.1.2.3.1 Deals 186
14.1.2.3.2 Expansions 187
14.1.2.4 MnM view 187
14.1.2.4.1 Right to win 187
14.1.2.4.2 Strategic choices 188
14.1.2.4.3 Weaknesses & competitive threats 188
14.1.3 MERCK KGAA 189
14.1.3.1 Business overview 189
14.1.3.2 Products offered 191
14.1.3.3 Recent developments 191
14.1.3.3.1 Deals 191
14.1.3.3.2 Expansions 192
14.1.3.3.3 Other developments 193
14.1.3.4 MnM view 194
14.1.3.4.1 Right to win 194
14.1.3.4.2 Strategic choices 194
14.1.3.4.3 Weaknesses & competitive threats 194
14.1.4 SARTORIUS AG 195
14.1.4.1 Business overview 195
14.1.4.2 Products offered 196
14.1.4.3 MnM view 197
14.1.4.3.1 Right to win 197
14.1.4.3.2 Strategic choices 197
14.1.4.3.3 Weaknesses & competitive threats 197
14.1.5 WATERS CORPORATION 198
14.1.5.1 Business overview 198
14.1.5.2 Products offered 199
14.1.5.3 Recent developments 200
14.1.5.3.1 Product launches 200
14.1.5.3.2 Deals 200
14.1.5.4 MnM view 201
14.1.5.4.1 Right to win 201
14.1.5.4.2 Strategic choices 201
14.1.5.4.3 Weaknesses & competitive threats 201
14.1.6 AGILENT TECHNOLOGIES, INC. 202
14.1.6.1 Business overview 202
14.1.6.2 Products offered 203
14.1.6.3 Recent developments 204
14.1.6.3.1 Product launches 204
14.1.6.3.2 Deals 204
14.1.6.3.3 Expansions 205
14.1.7 AVANTOR, INC. 206
14.1.7.1 Business overview 206
14.1.7.2 Products offered 207
14.1.8 BIO-RAD LABORATORIES, INC. 208
14.1.8.1 Business overview 208
14.1.8.2 Products offered 209
14.1.9 REPLIGEN CORPORATION 210
14.1.9.1 Business overview 210
14.1.9.2 Products offered 212
14.1.9.3 Recent developments 212
14.1.9.3.1 Product launches 212
14.1.9.3.2 Deals 213
14.1.10 SHIMADZU CORPORATION 214
14.1.10.1 Business overview 214
14.1.10.2 Products offered 215
14.1.10.3 Recent developments 216
14.1.10.3.1 Deals 216
14.1.11 ECOLAB INC. 217
14.1.11.1 Business overview 217
14.1.11.2 Products offered 218
14.1.11.3 Recent developments 219
14.1.11.3.1 Product launches 219
14.1.11.3.2 Deals 219
14.1.11.3.3 Expansions 219
14.1.12 TOSOH BIOSCIENCE 220
14.1.12.1 Business overview 220
14.1.12.2 Products offered 221
14.1.12.3 Recent developments 222
14.1.12.3.1 Expansions 222
14.2 OTHER PLAYERS 223
14.2.1 MITSUBISHI CHEMICAL CORPORATION 223
14.2.2 REVVITY 224
14.2.3 PERKINELMER 224
14.2.4 CECIL INSTRUMENTS LIMITED 225
14.2.5 W. R. GRACE & CO.-CONN 226
14.2.6 ECOM SPOL. S R.O 226
14.2.7 BÜCHI LABORTECHNIK AG 227
14.2.8 GOOD SCIENCE (TIANJIN) INSTRUMENT TECHNOLOGIES CO., LTD. 228
14.2.9 BIO WORKS TECHNOLOGIES 228
14.2.10 SYKAM GMBH 229
14.2.11 SUNRESIN NEW MATERIALS CO. LTD. 229
14.2.12 YMC CO., LTD. 230
14.2.13 GENO TECHNOLOGY INC. 230
15 RESEARCH METHODOLOGY 231
15.1 RESEARCH DATA 231
15.1.1 SECONDARY RESEARCH 232
15.1.1.1 Key secondary sources 233
15.1.1.2 Key data from secondary sources 233
15.1.1.3 Objectives of secondary research 234
15.1.2 PRIMARY RESEARCH 234
15.1.2.1 Key primary sources 235
15.1.2.2 Key supply- and demand-side participants 235
15.1.2.3 Breakdown of primary interviews 236
15.1.2.4 Objectives of primary research 236
15.1.2.5 Key primary insights 237
15.2 MARKET SIZE ESTIMATION 237
15.2.1 BOTTOM-UP APPROACH 238
15.2.1.1 Company revenue estimation 239
15.2.1.2 Customer-based market estimation 240
15.2.1.3 Primary interviews 241
15.2.2 TOP-DOWN APPROACH 241
15.3 GROWTH RATE ASSUMPTIONS 242
15.4 DATA TRIANGULATION 245
15.5 STUDY ASSUMPTIONS 246
15.6 RESEARCH LIMITATIONS 246
15.7 RISK ANALYSIS 246
16 APPENDIX 247
16.1 DISCUSSION GUIDE 247
16.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 252
16.3 CUSTOMIZATION OPTIONS 254
16.4 RELATED REPORTS 254
16.5 AUTHOR DETAILS 255
LIST OF TABLES
TABLE 1 PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET:
INCLUSIONS & EXCLUSIONS 27
TABLE 2 PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET: UNMET NEEDS 44
TABLE 3 OVERVIEW OF STRATEGIES ADOPTED BY KEY COMPANIES IN
PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET 45
TABLE 4 PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET:
PORTER’S FIVE FORCES ANALYSIS 48
TABLE 5 AVERAGE SELLING PRICE OF GC COLUMNS, BY KEY PLAYER, 2025 (USD) 56
TABLE 6 AVERAGE SELLING PRICE TREND OF PREPARATIVE AND PROCESS CHROMATOGRAPHY PRODUCTS, BY REGION, 2023–2025 (USD) 57
TABLE 7 IMPORT DATA FOR CHROMATOGRAPHS AND ELECTROPHORESIS INSTRUMENTS, BY COUNTRY, 2021–2024 (USD THOUSAND) 59
TABLE 8 EXPORT DATA FOR CHROMATOGRAPHS AND ELECTROPHORESIS INSTRUMENTS, BY COUNTRY, 2021–2024 (USD THOUSAND) 60
TABLE 9 PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET:
LIST OF MAJOR CONFERENCES AND EVENTS 60
TABLE 10 CASE STUDY 1: BIO-WORKS TECHNOLOGIES – WORKBEADS
AFFIMAB FOR MONOCLONAL ANTIBODY PURIFICATION 64
TABLE 11 CASE STUDY 2: STATISTICAL APPROACHES TO DEVELOPMENT OF PROTEIN A AFFINITY CHROMATOGRAPHY FOR IMPROVING RECOVERY AND CONTROLLING QUALITY ATTRIBUTES OF MONOCLONAL ANTIBODIES 64
TABLE 12 CASE STUDY 3: CAPTURE CHROMATOGRAPHY WITH MIXED-MODE RESINS: A CASE STUDY WITH RECOMBINANT HUMAN THIOREDOXIN FROM ESCHERICHIA COLI 65
TABLE 13 US-ADJUSTED RECIPROCAL TARIFF RATES 67
TABLE 14 CASE STUDY 1: AI-GENERATED VS. IN-LAB HPLC METHOD OPTIMIZATION 73
TABLE 15 INTERCONNECTED ADJACENT ECOSYSTEMS & IMPACT ON MARKET PLAYERS 73
TABLE 16 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 75
TABLE 17 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 75
TABLE 18 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 76
TABLE 19 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 77
TABLE 20 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT
AGENCIES, AND OTHER ORGANIZATIONS 77
TABLE 21 INDUSTRY STANDARDS FOR PREPARATIVE AND
PROCESS CHROMATOGRAPHY MARKET 78
TABLE 22 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS (%) 81
TABLE 23 KEY BUYING CRITERIA, BY END USER 82
TABLE 24 PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET,
BY PRODUCT TYPE, 2024–2031 (USD MILLION) 85
TABLE 25 PROCESS CHROMATOGRAPHY PRODUCTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 86
TABLE 26 PROCESS CHROMATOGRAPHY PRODUCTS MARKET, BY REGION,
2024–2031 (USD MILLION) 86
TABLE 27 PROCESS CHROMATOGRAPHY PRODUCTS MARKET FOR CHEMICALS &
REAGENTS, BY REGION, 2024–2031 (USD MILLION) 87
TABLE 28 PROCESS CHROMATOGRAPHY PRODUCTS MARKET FOR RESINS,
BY REGION, 2024–2031 (USD MILLION) 88
TABLE 29 PROCESS CHROMATOGRAPHY PRODUCTS MARKET FOR COLUMNS,
BY REGION, 2024–2031 (USD MILLION) 89
TABLE 30 PROCESS CHROMATOGRAPHY PRODUCTS MARKET FOR SYSTEMS,
BY REGION, 2024–2031 (USD MILLION) 90
TABLE 31 PROCESS CHROMATOGRAPHY PRODUCTS MARKET FOR AFTER-MARKET SERVICES, BY REGION, 2024–2031 (USD MILLION) 91
TABLE 32 PREPARATIVE CHROMATOGRAPHY PRODUCTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 92
TABLE 33 PREPARATIVE CHROMATOGRAPHY PRODUCTS MARKET, BY REGION,
2024–2031 (USD MILLION) 92
TABLE 34 PREPARATIVE CHROMATOGRAPHY PRODUCTS MARKET FOR CHEMICALS & REAGENTS, BY REGION, 2024–2031 (USD MILLION) 93
TABLE 35 PREPARATIVE CHROMATOGRAPHY PRODUCTS MARKET FOR RESINS,
BY REGION, 2024–2031 (USD MILLION) 94
TABLE 36 PREPARATIVE CHROMATOGRAPHY PRODUCTS MARKET FOR COLUMNS,
BY REGION, 2024–2031 (USD MILLION) 95
TABLE 37 PREPARATIVE CHROMATOGRAPHY PRODUCTS MARKET FOR SYSTEMS,
BY REGION, 2024–2031 (USD MILLION) 96
TABLE 38 PREPARATIVE CHROMATOGRAPHY PRODUCTS MARKET FOR AFTER-MARKET SERVICES, BY REGION, 2024–2031 (USD MILLION) 97
TABLE 39 PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 99
TABLE 40 PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET FOR MONOCLONAL ANTIBODIES & RECOMBINANT PROTEINS, BY REGION, 2024–2031 (USD MILLION) 100
TABLE 41 PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET FOR VACCINES,
BY REGION, 2024–2031 (USD MILLION) 101
TABLE 42 PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET FOR PEPTIDES & OLIGONUCLEOTIDES, BY REGION, 2024–2031 (USD MILLION) 102
TABLE 43 PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET FOR CELL
& GENE THERAPIES, BY REGION, 2024–2031 (USD MILLION) 102
TABLE 44 PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET
FOR OTHER APPLICATIONS, BY REGION, 2024–2031 (USD MILLION) 103
TABLE 45 PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET,
BY END USER, 2024–2031 (USD MILLION) 105
TABLE 46 PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2024–2031 (USD MILLION) 106
TABLE 47 PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET FOR FOOD & NUTRACEUTICAL COMPANIES, BY REGION, 2024–2031 (USD MILLION) 107
TABLE 48 PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2024–2031 (USD MILLION) 108
TABLE 49 PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET
FOR OTHER END USERS, BY REGION, 2024–2031 (USD MILLION) 109
TABLE 50 PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET,
BY REGION, 2024–2031 (USD MILLION) 111
TABLE 51 NORTH AMERICA: KEY MACROINDICATORS 113
TABLE 52 NORTH AMERICA: PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 113
TABLE 53 NORTH AMERICA: PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET,
BY PRODUCT TYPE, 2024–2031 (USD MILLION) 113
TABLE 54 NORTH AMERICA: PROCESS CHROMATOGRAPHY PRODUCTS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 114
TABLE 55 NORTH AMERICA: PREPARATIVE CHROMATOGRAPHY PRODUCTS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 114
TABLE 56 NORTH AMERICA: PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET,
BY APPLICATION, 2024–2031 (USD MILLION) 115
TABLE 57 NORTH AMERICA: PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET,
BY END USER, 2024–2031 (USD MILLION) 115
TABLE 58 US: PROCESS CHROMATOGRAPHY PRODUCTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 116
TABLE 59 US: PREPARATIVE CHROMATOGRAPHY PRODUCTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 116
TABLE 60 CANADA: PROCESS CHROMATOGRAPHY PRODUCTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 117
TABLE 61 CANADA: PREPARATIVE CHROMATOGRAPHY PRODUCTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 118
TABLE 62 EUROPE: KEY MACROINDICATORS 119
TABLE 63 EUROPE: PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 119
TABLE 64 EUROPE: PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 119
TABLE 65 EUROPE: PROCESS CHROMATOGRAPHY PRODUCTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 120
TABLE 66 EUROPE: PREPARATIVE CHROMATOGRAPHY PRODUCTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 120
TABLE 67 EUROPE: PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET,
BY APPLICATION, 2024–2031 (USD MILLION) 121
TABLE 68 EUROPE: PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET,
BY END USER, 2024–2031 (USD MILLION) 121
TABLE 69 GERMANY: PROCESS CHROMATOGRAPHY PRODUCTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 122
TABLE 70 GERMANY: PREPARATIVE CHROMATOGRAPHY PRODUCTS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 123
TABLE 71 UK: PROCESS CHROMATOGRAPHY PRODUCTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 124
TABLE 72 UK: PREPARATIVE CHROMATOGRAPHY PRODUCTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 124
TABLE 73 FRANCE: PROCESS CHROMATOGRAPHY PRODUCTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 125
TABLE 74 FRANCE: PREPARATIVE CHROMATOGRAPHY PRODUCTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 125
TABLE 75 ITALY: PROCESS CHROMATOGRAPHY PRODUCTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 126
TABLE 76 ITALY: PREPARATIVE CHROMATOGRAPHY PRODUCTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 127
TABLE 77 SPAIN: PROCESS CHROMATOGRAPHY PRODUCTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 128
TABLE 78 SPAIN: PREPARATIVE CHROMATOGRAPHY PRODUCTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 128
TABLE 79 REST OF EUROPE: PROCESS CHROMATOGRAPHY PRODUCTS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 129
TABLE 80 REST OF EUROPE: PREPARATIVE CHROMATOGRAPHY PRODUCTS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 129
TABLE 81 ASIA PACIFIC: KEY MACROINDICATORS 131
TABLE 82 ASIA PACIFIC: PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 131
TABLE 83 ASIA PACIFIC: PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET,
BY PRODUCT TYPE, 2024–2031 (USD MILLION) 132
TABLE 84 ASIA PACIFIC: PROCESS CHROMATOGRAPHY PRODUCTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 132
TABLE 85 ASIA PACIFIC: PREPARATIVE CHROMATOGRAPHY PRODUCTS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 132
TABLE 86 ASIA PACIFIC: PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET,
BY APPLICATION, 2024–2031 (USD MILLION) 133
TABLE 87 ASIA PACIFIC: PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET,
BY END USER, 2024–2031 (USD MILLION) 133
TABLE 88 JAPAN: PROCESS CHROMATOGRAPHY PRODUCTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 134
TABLE 89 JAPAN: PREPARATIVE CHROMATOGRAPHY PRODUCTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 134
TABLE 90 CHINA: PROCESS CHROMATOGRAPHY PRODUCTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 135
TABLE 91 CHINA: PREPARATIVE CHROMATOGRAPHY PRODUCTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 136
TABLE 92 INDIA: PROCESS CHROMATOGRAPHY PRODUCTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 137
TABLE 93 INDIA: PREPARATIVE CHROMATOGRAPHY PRODUCTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 137
TABLE 94 AUSTRALIA: PROCESS CHROMATOGRAPHY PRODUCTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 138
TABLE 95 AUSTRALIA: PREPARATIVE CHROMATOGRAPHY PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 138
TABLE 96 SOUTH KOREA: PROCESS CHROMATOGRAPHY PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 139
TABLE 97 SOUTH KOREA: PREPARATIVE CHROMATOGRAPHY PRODUCTS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 140
TABLE 98 REST OF ASIA PACIFIC: PROCESS CHROMATOGRAPHY PRODUCTS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 141
TABLE 99 REST OF ASIA PACIFIC: PREPARATIVE CHROMATOGRAPHY PRODUCTS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 141
TABLE 100 LATIN AMERICA: KEY MACROINDICATORS 142
TABLE 101 LATIN AMERICA: PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 142
TABLE 102 LATIN AMERICA: PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET,
BY PRODUCT TYPE, 2024–2031 (USD MILLION) 143
TABLE 103 LATIN AMERICA: PROCESS CHROMATOGRAPHY PRODUCTS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 143
TABLE 104 LATIN AMERICA: PREPARATIVE CHROMATOGRAPHY PRODUCTS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 143
TABLE 105 LATIN AMERICA: PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET,
BY APPLICATION, 2024–2031 (USD MILLION) 144
TABLE 106 LATIN AMERICA: PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET,
BY END USER, 2024–2031 (USD MILLION) 144
TABLE 107 BRAZIL: PROCESS CHROMATOGRAPHY PRODUCTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 145
TABLE 108 BRAZIL: PREPARATIVE CHROMATOGRAPHY PRODUCTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 146
TABLE 109 MEXICO: PROCESS CHROMATOGRAPHY PRODUCTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 147
TABLE 110 MEXICO: PREPARATIVE CHROMATOGRAPHY PRODUCTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 147
TABLE 111 REST OF LATIN AMERICA: PROCESS CHROMATOGRAPHY PRODUCTS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 148
TABLE 112 REST OF LATIN AMERICA: PREPARATIVE CHROMATOGRAPHY PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 148
TABLE 113 MIDDLE EAST & AFRICA: KEY MACROINDICATORS 149
TABLE 114 MIDDLE EAST & AFRICA: PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET, BY REGION, 2024–2031 (USD MILLION) 149
TABLE 115 MIDDLE EAST & AFRICA: PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 150
TABLE 116 MIDDLE EAST & AFRICA: PROCESS CHROMATOGRAPHY PRODUCTS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 150
TABLE 117 MIDDLE EAST & AFRICA: PREPARATIVE CHROMATOGRAPHY PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 150
TABLE 118 MIDDLE EAST & AFRICA: PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 151
TABLE 119 MIDDLE EAST & AFRICA: PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET, BY END USER, 2024–2031 (USD MILLION) 151
TABLE 120 GCC COUNTRIES: PROCESS CHROMATOGRAPHY PRODUCTS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 152
TABLE 121 GCC COUNTRIES: PREPARATIVE CHROMATOGRAPHY PRODUCTS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 153
TABLE 122 REST OF MIDDLE EAST & AFRICA: PROCESS CHROMATOGRAPHY PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 154
TABLE 123 REST OF MIDDLE EAST & AFRICA: PREPARATIVE CHROMATOGRAPHY PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 154
TABLE 124 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET, 2022–2025 156
TABLE 125 PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET:
DEGREE OF COMPETITION 159
TABLE 126 PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET: REGION FOOTPRINT 167
TABLE 127 PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET:
PRODUCT TYPE FOOTPRINT 168
TABLE 128 PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET:
APPLICATION FOOTPRINT 169
TABLE 129 PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET: END-USER FOOTPRINT 170
TABLE 130 PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET:
DETAILED LIST OF KEY STARTUPS/SME PLAYERS, 2025 173
TABLE 131 PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SME PLAYERS, BY PRODUCT
TYPE AND REGION 174
TABLE 132 PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET:
PRODUCT LAUNCHES, JANUARY 2022–JANUARY 2026 176
TABLE 133 PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET:
DEALS, JANUARY 2022–JANUARY 2026 176
TABLE 134 PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET: EXPANSIONS, JANUARY 2022–JANUARY 2026 177
TABLE 135 DANAHER: COMPANY OVERVIEW 179
TABLE 136 DANAHER: PRODUCTS OFFERED 181
TABLE 137 DANAHER: PRODUCT LAUNCHES, JANUARY 2022–DECEMBER 2025 181
TABLE 138 DANAHER: DEALS, JANUARY 2022–DECEMBER 2025 182
TABLE 139 DANAHER: EXPANSIONS, JANUARY 2022–JULY 2025 182
TABLE 140 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 184
TABLE 141 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED 186
TABLE 142 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2022–SEPTEMBER 2025 186
TABLE 143 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS, JANUARY 2022–JULY 2025 187
TABLE 144 MERCK KGAA: COMPANY OVERVIEW 189
TABLE 145 MERCK KGAA: PRODUCTS OFFERED 191
TABLE 146 MERCK KGAA: DEALS, JANUARY 2022–DECEMBER 2025 191
TABLE 147 MERCK KGAA: EXPANSIONS, JANUARY 2022–DECEMBER 2025 192
TABLE 148 MERCK KGAA: OTHER DEVELOPMENTS, JANUARY 2022–DECEMBER 2025 193
TABLE 149 SARTORIUS AG COMPANY OVERVIEW 195
TABLE 150 SARTORIUS AG: PRODUCTS OFFERED 196
TABLE 151 WATERS CORPORATION: COMPANY OVERVIEW 198
TABLE 152 WATERS CORPORATION: PRODUCTS OFFERED 199
TABLE 153 WATERS CORPORATION: PRODUCT LAUNCHES, JANUARY 2022–DECEMBER 2025 200
TABLE 154 WATERS CORPORATION: DEALS, JANUARY 2022–SEPTEMBER 2025 200
TABLE 155 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW 202
TABLE 156 AGILENT TECHNOLOGIES, INC.: PRODUCTS OFFERED 203
TABLE 157 AGILENT TECHNOLOGIES, INC.: PRODUCT LAUNCHES,
JANUARY 2022–DECEMBER 2025 204
TABLE 158 AGILENT TECHNOLOGIES, INC.: DEALS, JANUARY 2022–DECEMBER 2025 204
TABLE 159 AGILENT TECHNOLOGIES, INC.: EXPANSIONS, JANUARY 2022–SEPTEMBER 2025 205
TABLE 160 AVANTOR, INC.: COMPANY OVERVIEW 206
TABLE 161 AVATOR, INC.: PRODUCTS OFFERED 207
TABLE 162 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW 208
TABLE 163 BIO-RAD LABORATORIES, INC.: PRODUCTS OFFERED 209
TABLE 164 REPLIGEN CORPORATION: COMPANY OVERVIEW 210
TABLE 165 REPLIGEN CORPORATION: PRODUCTS OFFERED 212
TABLE 166 REPLIGEN CORPORATION: PRODUCT LAUNCHES,
JANUARY 2022–DECEMBER 2025 212
TABLE 167 REPLIGEN CORPORATION: DEALS, JANUARY 2022–DECEMBER 2025 213
TABLE 168 SHIMADZU CORPORATION: COMPANY OVERVIEW 214
TABLE 169 SHIMADZU CORPORATION: PRODUCTS OFFERED 215
TABLE 170 SHIMADZU CORPORATION: DEALS, JANUARY 2022–DECEMBER 2025 216
TABLE 171 ECOLAB INC.: COMPANY OVERVIEW 217
TABLE 172 ECOLAB INC: PRODUCTS OFFERED 218
TABLE 173 ECOLAB INC.: PRODUCT LAUNCHES, JANUARY 2022–DECEMBER 2025 219
TABLE 174 ECOLAB INC.: DEALS, JANUARY 2022–DECEMBER 2025 219
TABLE 175 ECOLAB INC.: EXPANSIONS, JANUARY 2022–DECEMBER 2025 219
TABLE 176 TOSOH BIOSCIENCE: COMPANY OVERVIEW 220
TABLE 177 TOSOH BIOSCIENCE: PRODUCTS OFFERED 221
TABLE 178 TOSOH BIOSCIENCE: EXPANSIONS, JANUARY 2022–DECEMBER 2025 222
TABLE 179 MITSUBISHI CHEMICAL CORPORATION: COMPANY OVERVIEW 223
TABLE 180 REVVITY: COMPANY OVERVIEW 224
TABLE 181 PERKINELMER: COMPANY OVERVIEW 224
TABLE 182 CECIL INSTRUMENTS LIMITED: COMPANY OVERVIEW 225
TABLE 183 W. R. GRACE & CO.-CONN: COMPANY OVERVIEW 226
TABLE 184 ECOM SPOL. S R.O.: COMPANY OVERVIEW 226
TABLE 185 BÜCHI LABORTECHNIK AG: COMPANY OVERVIEW 227
TABLE 186 GOOD SCIENCE (TIANJIN) INSTRUMENT TECHNOLOGIES CO., LTD.:
COMPANY OVERVIEW 228
TABLE 187 BIO WORKS TECHNOLOGIES: COMPANY OVERVIEW 228
TABLE 188 SYKAM GMBH: COMPANY OVERVIEW 229
TABLE 189 SUNRESIN NEW MATERIALS CO. LTD.: COMPANY OVERVIEW 229
TABLE 190 YMC CO., LTD.: COMPANY OVERVIEW 230
TABLE 191 GENO TECHNOLOGY INC.: COMPANY OVERVIEW 230
TABLE 192 PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET: STUDY ASSUMPTIONS 246
TABLE 193 PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET: RISK ANALYSIS 246
LIST OF FIGURES
FIGURE 1 PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET
SEGMENTATION & REGIONAL SCOPE 26
FIGURE 2 PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET: YEARS CONSIDERED 28
FIGURE 3 MARKET SCENARIO 30
FIGURE 4 GLOBAL PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET, 2023–2031 31
FIGURE 5 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN PREPARATIVE
AND PROCESS CHROMATOGRAPHY MARKET, 2024–2025 31
FIGURE 6 DISRUPTIONS INFLUENCING GROWTH OF PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET 32
FIGURE 7 HIGH-GROWTH SEGMENTS IN PREPARATIVE AND PROCESS
CHROMATOGRAPHY MARKET, 2025–2031 33
FIGURE 8 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD 34
FIGURE 9 INCREASED PRODUCTION OF MONOCLONAL ANTIBODIES TO DRIVE DEMAND FOR BIOPROCESSING AND SEPARATION PRODUCTS 35
FIGURE 10 CHINA AND JAPAN TO ACQUIRE A MAJOR SHARE OF MARKET
IN ASIA PACIFIC IN 2025 36
FIGURE 11 INDIA TO REGISTER HIGHEST CAGR FROM 2026 TO 2030 37
FIGURE 12 PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 38
FIGURE 13 PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET:
PORTER’S FIVE FORCES ANALYSIS 48
FIGURE 14 PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET:
SUPPLY CHAIN ANALYSIS 51
FIGURE 15 PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET:
VALUE CHAIN ANALYSIS 53
FIGURE 16 PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET: ECOSYSTEM ANALYSIS 54
FIGURE 17 AVERAGE SELLING PRICE OF GC COLUMNS, BY KEY PLAYER, 2025 (USD) 56
FIGURE 18 AVERAGE SELLING PRICE OF PREPARATIVE AND PROCESS CHROMATOGRAPHY PRODUCTS, BY REGION, 2025 (USD) 57
FIGURE 19 PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET: IMPORT SCENARIO FOR CHROMATOGRAPHS AND ELECTROPHORESIS INSTRUMENTS
(HS CODE 902720) 58
FIGURE 20 PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET: EXPORT SCENARIO FOR CHROMATOGRAPHS AND ELECTROPHORESIS INSTRUMENTS
(HS CODE 902720) 59
FIGURE 21 PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 62
FIGURE 22 PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET: INVESTMENT & FUNDING SCENARIO, 2019–2023 62
FIGURE 23 PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET:
NUMBER OF INVESTOR DEALS, BY KEY PLAYER, 2019–2023 63
FIGURE 24 PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET:
VALUE OF INVESTOR DEALS, BY KEY PLAYER, 2019–2023 (USD MILLION) 63
FIGURE 25 PATENT ANALYSIS FOR PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET (JANUARY 2015–JANUARY 2026) 71
FIGURE 26 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR
TOP FOUR END USERS 80
FIGURE 27 KEY BUYING CRITERIA, BY END USER 81
FIGURE 28 NORTH AMERICA: PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET SNAPSHOT (2024) 112
FIGURE 29 ASIA PACIFIC: PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET SNAPSHOT (2025) 130
FIGURE 30 REVENUE ANALYSIS OF KEY PLAYERS IN PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET, 2020–2024 (USD MILLION) 158
FIGURE 31 MARKET SHARE ANALYSIS OF KEY PLAYERS IN PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET (2025) 159
FIGURE 32 MARKET RANKING OF KEY PLAYERS IN PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET (2025) 161
FIGURE 33 EV/EBITDA OF TOP THREE PLAYERS (2026) 161
FIGURE 34 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK
BETA OF TOP THREE PLAYERS (2026) 162
FIGURE 35 PREPARATIVE AND PROCESS CHROMATOGRAPHY: BRAND/PRODUCT COMPARATIVE ANALYSIS 163
FIGURE 36 PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025 165
FIGURE 37 PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET: COMPANY FOOTPRINT 166
FIGURE 38 PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025 172
FIGURE 39 DANAHER: COMPANY SNAPSHOT (2024) 180
FIGURE 40 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2024) 185
FIGURE 41 MERCK KGAA: COMPANY SNAPSHOT (2024) 190
FIGURE 42 SARTORIUS AG: COMPANY SNAPSHOT (2024) 196
FIGURE 43 WATERS CORPORATION: COMPANY SNAPSHOT (2024) 199
FIGURE 44 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2025) 203
FIGURE 45 AVANTOR, INC.: COMPANY SNAPSHOT (2024) 207
FIGURE 46 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2024) 208
FIGURE 47 REPLIGEN CORPORATION: COMPANY SNAPSHOT (2024) 211
FIGURE 48 SHIMADZU CORPORATION: COMPANY SNAPSHOT (2025) 215
FIGURE 49 ECOLAB INC.: COMPANY SNAPSHOT (2024) 218
FIGURE 50 TOSOH BIOSCIENCE: COMPANY SNAPSHOT (2024) 221
FIGURE 51 PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET: RESEARCH DATA 231
FIGURE 52 PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET: RESEARCH DESIGN 232
FIGURE 53 PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET:
KEY SECONDARY SOURCES 233
FIGURE 54 PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET:
KEY DATA FROM SECONDARY SOURCES 233
FIGURE 55 PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET:
KEY PRIMARY SOURCES (DEMAND AND SUPPLY SIDES) 235
FIGURE 56 PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET:
KEY SUPPLY- AND DEMAND-SIDE PARTICIPANTS 235
FIGURE 57 PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET: BREAKDOWN OF PRIMARY INTERVIEWS (BY COMPANY TYPE, DESIGNATION, AND REGION) 236
FIGURE 58 PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET:
KEY INSIGHTS FROM PRIMARY EXPERTS 237
FIGURE 59 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 238
FIGURE 60 PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET:
COMPANY REVENUE ESTIMATION 239
FIGURE 61 PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET: END-USER AND REVENUE MAPPING-BASED MARKET SIZE ESTIMATION METHODOLOGY 240
FIGURE 62 PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET: TOP-DOWN APPROACH 241
FIGURE 63 GROWTH PROJECTIONS ON REVENUE IMPACT OF KEY MACROINDICATORS 243
FIGURE 64 PREPARATIVE AND PROCESS CHROMATOGRAPHY MARKET:
DATA TRIANGULATION METHODOLOGY 245
